Skip to search formSkip to main contentSkip to account menu

monoclonal antibody BEC2

Known as: Anti-idiotypic Monoclonal Antibody BEC2, anti-idiotypic murine monoclonal antibody BEC2, BEC-2 
A murine anti-idiotypic monoclonal antibody (anti-Id MoAb) that is directed against an idiotype mimicking a disialoganglioside GD3. GD3 represents a… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
7020 Background: Attempts to maintain the response to initial therapy have been unsuccessful in SCLC. BEC2 is a murine IgG2b… 
2001
2001
BACKGROUND Several lines of evidence have suggested a role for cAMP (adenosine 3',5'-cyclic monophosphate) signaling in the acute… 
Review
1999
Review
1999
In the last 25 years, treatment for small cell lung cancer (SCLC) has improved with advances in chemotherapy and radiotherapy… 
1996
1996
The cross‐reactive idiotype (Hu‐SJ‐CRIM) is defined by polyclonal human anti‐idiotypic antibodies derived from chronically S… 
1991
1991
Anti-idiotypic monoclonal antibodies (MoAbs) were prepared in a syngeneic system against anti-carcinoembryonic antigen (CEA) MoAb… 
1988
1988
Although the structural basis of internal images borne by beta type monoclonal anti-idiotypic antibody (Ab2) begins to be… 
Highly Cited
1984
Highly Cited
1984
Prolonged treatment of mice, starting at birth, with rabbit anti-mouse mu-chain antibodies resulted in the elimination of…